Reportedly, CD19+IL-10+ (more precisely, CD19+CD5+CD1d+ and CD19+CD24+CD38+ subsets) Breg cell numbers are significantly lower in peripheral blood and thymus of MG patients compared to healthy controls, and that correlates with disease severity (59–61). This evidence concerns the gene CD19 and myasthenia gravis.